RE:RE:RE:take a breakjammingthepipeline wrote: I understand what you are saying. But what I find annoying is the very low volume what translates in a lack of interest in this company. Anyway, we are 10% lower than the last PP and still no bids.
JTP, as great a diagnostic tool that 3D is, it is still just software. It needs a partner, jv, buy out from someone who will use the software in real time. Somebody like Johnson and Johnson or Roche need to step up and take 3D to the next level